Mirza Beg, MD
Rheumatology · Huntington, WVNPI 1710183066
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,250 of the $19,979 with a category attached, or 81.3%. AbbVie accounts for 83.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $18,570 and has fallen 98.7% since, to $245 in 2025.
Across 202 payments — averaging $98.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- Amgen$597
- Lilly USA, LLC$352
- E.r. Squibb & Sons, L.L.C.$313
- Novartis$272
- Novo Nordisk$249
- plus $1K from 21 others
Across 1 payment — averaging $7000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dr.reddy's Laboratories,inc.$7K
What the payments were for
- Speaking & faculty fees$16,25081%
- Travel & lodging$170%
- Food & beverage$3,67618%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $16,736 |
| Amgen(2 entities) | 26 | $597 |
| Lilly USA, LLC | 22 | $352 |
| E.r. Squibb & Sons, L.L.C. | 18 | $313 |
| Novartis | 17 | $272 |
| Novo Nordisk | 17 | $249 |
| UCB, Inc. | 4 | $245 |
| Johnson & Johnson(2 entities) | 15 | $186 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Sanofi | 6 | $121 |
| GSK | 8 | $119 |
| ANI Pharmaceuticals, Inc. | 1 | $100 |
| Esperion Therapeutics, Inc. | 4 | $77 |
| Genentech USA, Inc. | 5 | $68 |
| Boston Scientific | 3 | $68 |
| Arbor Pharmaceuticals, Inc. | 4 | $60 |
| Pfizer | 3 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $53 |
| Ironwood Pharmaceuticals, Inc | 3 | $35 |
| SK Life Science, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Medexus Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,979 in reported general payments places this provider in the 85th percentile of 26 rheumatology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $93,199 |
| Humira PenAdalimumab | 11 | $72,728 |
| Leflunomide | 18 | $1,637 |
| MethotrexateMethotrexate Sodium | 47 | $962 |
| Hydroxychloroquine Sulfate | 17 | $762 |
| Prednisone | 84 | $271 |
| Gabapentin | 11 | $103 |
| Folic Acid | 16 | $84 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Huntington
- Aesha SinghHuntington$2K
- Ralph WebbHuntington$0
- Wassim SaikaliBeckley$1.1M
- Suzanne GharibSouth Charleston$581K
- Michael IstfanSouth Charleston$25K
- Leah TriplettCharleston$19K
- Brian HoustonMorgantown$10K
- Charles JusticeCharleston$6K
- Michael RezaianMartinsburg$5K
- Arash HassantoufighiMartinsburg$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.